Dr. Tarig Fadalla is a medical doctor and clinical researcher at Soba University Hospital, Khartoum, Sudan. his research work focuses on strengthening stroke healthcare services in Africa by mapping service availability and highlighting the defects. Currently, he is investigating the availability and cost-effectiveness of IV Thrombolysis and Mechanical Thrombectomy in Africa. Moreover, he is studying the contributing factors of barriers that African clinicians face to access training programs in Neurology/Neurosurgery.

Furthermore, Dr. Fadalla served as Sudan’s National Leader Investigator in the African Surgical Outcomes Study (ASOS-2), which is a landmark continental cluster-randomized controlled trial involving African researchers from 28 African countries that aimed to address the problem of post-operative death in patients in Africa. The trial successfully recruited 28892 patients from 332 hospitals in 28 African countries that participated in the trial between May 2019 and July 2020, and it shows clearly that large-scale, multi-country, randomized controlled trials led by African Researchers in Africa are feasible.

Dr. Fadalla has published several scientific papers indexed in PubMed as well as presented many scientific posters at international conferences such as  “patterns, treatment, and outcomes of Subarachnoid hemorrhage in Sudan: a single center experience” at the EANS Congress 2020. In addition to “Moyamoya syndrome and stroke among pediatric sickle cell disease patients in Sudan” at MENA-SINO conference 2021. His career goal is to become a clinician-scientist, conducting translational research as well as being involved in the management of patients with brain disorders.